Crestline Management, L.P. 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Crestline Management, L.P. disclosed 3 US equity positions worth $53.5m in its Q2 2026 13F filing. The largest position was DNLI at 91.9% of the reported book, followed by SANA and EGHT. Against the Q1 2026 filing, it opened 0 new positions, added to 0 and reduced 1 among the top 3 holdings.
What did Crestline Management, L.P. own in Q2 2026? Top 3 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | DNLI DENALI THERAPEUTICS INC | Healthcare | 91.9% | $49.1m | 1,910,732 | -14% | reduced |
| 2 | SANA SANA BIOTECHNOLOGY INC | Healthcare | 4.9% | $2.6m | 755,736 | 0% | held |
| 3 | EGHT 8X8 INC NEW | Technology | 3.2% | $1.7m | 990,850 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.